Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
Clinical trial NCT06334393 · COMPLETED
Trial details
- NCT number
- NCT06334393
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2025-04-21
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.